Myogenic stem cells for the therapy of primary myopathies: Wishful thinking or therapeutic perspective?

Journal of Clinical Investigation

Volumn 105, Issue 12, 2000, Pages 1669-1674

  Cossu, Giulio ^a,c   Mavilio, Fulvio ^b  

^a Stem Cell Research Institute   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE ASSOCIATION; DUCHENNE MUSCULAR DYSTROPHY; MUSCLE REGENERATION; MYOBLAST; MYOPATHY; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION;

EID: 0033917878     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI10376     Document Type: Review

References (35)

1. Nawrotzki, R., Blake, D.J., and Davies, K.E. 1996. The genetic basis of neuromuscular disorders. Trends Genet. 12:294-298.
2. Miller, J.B., Schaefer, L., and Dominov, J.A. 1999. Seeking muscle stem cells. Curr. Top. Dev. Biol. 43:191-219.
3. Kochanek, S., et al. 1996. A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase. Proc. Natl. Acad. Sci. USA. 93:5731-5736.
4. Tinsley, J.M., et al. 1996. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature. 384:349-353.
5. Partridge, T.A., Beauchamp, J.R., and Morgan, J.E. 1989. Conversion of mdx myofibers from dystrophin-negative to -positive by injection of normal myoblasts. Nature. 337:176-179.
6. Beauchamp, J.R., Pagel, C.N., and Partridge, T.A. 1997 A dual-marker system for quantitative studies of myoblast transplantation in the mouse. Transplantation. 63:1794-1797.
7. Ohtsuka, Y., Udaka, K., Yamashiro, Y., Yagita, H., and Okumura, K. 1998. Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: implication for gene therapy. J. Immunol. 160:4635-4640.
8. Qu, Z., et al. 1998. Development of approaches to improve cell survival in myoblast transfer therapy. J. Cell Biol. 142:1257-1267.
9. Beauchamp, J.R., Morgan, J.E., Pagel, C.N., and Partridge, T.A. 1999. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J. Cell Biol. 144:1113-1122.
10. Guerette, G., et al. 1997. Prevention by anti-LFA-1 of acute myoblast death following transplantation. J. Immunol. 159:2522-2531.
11. Kinoshita, I., et al. 1996. Myoblast transplantation in monkeys: control of immune response by FK-506. J. Neuropathol Exp. Neurol. 55:687-697.
12. Blau, H.M., and Springer, M.L. 1997. Muscle-mediated gene therapy. N. Eng. J. Med. 333:1554-1556.
13. Decary, S., et al. 1997. Replicative potential and telomere length in human skeletal muscle: implication for myogenic cell-mediated gene therapy. Hum. Gene Ther. 4:713-723.
14. Salvatori, G., et al. 1993. Retroviral vector-mediated gene transfer into human primary myogenic cells leads to expression in muscle fibers in vivo. Hum. Gene Ther. 4:713-723.
15. Huard, J., Verreault, S., Roy, R., Tremblay, M., and Tremblay, J.P. 1994. High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice. J. Clin. Invest. 93:586-599.
16. Simon, L.V., Beauchamp, J.R., O'Hare, M., and Olsen, I. 1996. Establishment of long-term myogenic cultures from patients with Duchenne muscular dystrophy by retroviral transduction of a temperature-sensitive SV40 large T antigen. Exp. Cell Res. 224:264-271.
17. Salvatori, G., et al. 1997. A temperature conditional mutant of SV40 large T antigen requires serum to inhibit myogenesis and does not induce DNA synthesis in myotubes. Cell Growth Differ. 8:157-164.
18. Berghella, L., et al. 1999. Reversible immortalization of human myogenic cells by site-specific excision of a retrovirally transferred oncogene. Hum. Gene Ther. 10:1607-1617.
19. Lattanzi, L., et al. 1998. High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies. J. Clin. Invest. 101:2119-2128.
20. Huard, C., et al. 1998. Transplantation of dermal fibroblasts expressing MyoD1 in mouse muscles. Biochem. Biophys. Res. Commun. 248:648-654.
21. Cossu, G. 1997. Unorthodox myogenesis: possible developmental significance and implications for tissue histogenesis and regeneration. Histol. Histopathol. 12:755-760.
22. Kelly, R., Alonso, S., Tajbakhsh, S., Cossu, G., and Buckingham, M. 1995. Myosin light chain 3F regulatory sequences confer regionalized cardiac and skeletal muscle expression in transgenic mice. J. Cell Biol. 129:383-396.
23. Prockop, D.J. 1997. Marrow stromal cells as stem cells for non-hematopoietic tissues. Science. 276:71-74.
24. Bianco, P., and Robey, P.G. 2000. Marrow stromal stem cells. J. Clin. Invest. 105:1663-1668.
25. Bianco, P., and Cossu, G. 1999. Uno, nessuno e centomila: searching for the identity of mesodermal progenitors. Exp. Cell. Res. 251:257-263.
26. Ferrari, G., et al. 1998. Muscle regeneration by bone marrow-derived myogenic progenitors. Science. 279:1528-1530.
27. Gussoni, E., et al. 1999. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature. 401:390-394.
28. Goodell, M.A., et al. 1997. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat. Med. 3:1337-1345.
29. Jackson, K.A., Mi, T., and Goodell, M.A. 1999. Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc. Natl. Acad. Sci. USA. 96:14482-14486.
30. Bjornson, C.R., Rietze, R.L., Reynolds, B.A., Magli, M.C., and Vescovi, A.L. 1999. Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science. 283:534-537.
31. Dzierzak, E., Medvinsky, A., and de Bruijn, M. 1998. Qualitative and quantitative aspects of haematopoietic cell development in the mammalian embryo. Immunol. Today. 19:228-236.
32. De Angelis, L., et al. 1999. Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration. J. Cell Biol. 147:869-878.
33. Asahara, T., et al. 1999. Bone marrow origin of endothelial progenitor cells responsible for post-natal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85:221-228.
34. Robertson, S.M., Kennedy, M., Shannon, J.M., and Keller, G. 2000. A transitional stage in the commitment of mesoderm to hematopoiesis requiring the transcription factor SCL/tal-1. Development. 127:2447-2459.
35. Katagiri, T., et al. 1994. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 127:1755-1766.